The WEISS Lab


Pathophysiology of Ion Channels

A rare CACNA1H variant associated with amyotrophic lateral sclerosis causes complete loss of Cav3.2 T-type channel activity


Journal article


Robin N Stringer, Bohumila Jurkovicova-Tarabova, Sun Huang, O. Haji-Ghassemi, Romane Idoux, A. Liashenko, I. A. Souza, Y. Rzhepetskyy, Ľ. Lacinová, F. van Petegem, G. Zamponi, R. Pamphlett, N. Weiss
Molecular Brain, 2020

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA
Stringer, R. N., Jurkovicova-Tarabova, B., Huang, S., Haji-Ghassemi, O., Idoux, R., Liashenko, A., … Weiss, N. (2020). A rare CACNA1H variant associated with amyotrophic lateral sclerosis causes complete loss of Cav3.2 T-type channel activity. Molecular Brain.

Chicago/Turabian
Stringer, Robin N, Bohumila Jurkovicova-Tarabova, Sun Huang, O. Haji-Ghassemi, Romane Idoux, A. Liashenko, I. A. Souza, et al. “A Rare CACNA1H Variant Associated with Amyotrophic Lateral Sclerosis Causes Complete Loss of Cav3.2 T-Type Channel Activity.” Molecular Brain (2020).

MLA
Stringer, Robin N., et al. “A Rare CACNA1H Variant Associated with Amyotrophic Lateral Sclerosis Causes Complete Loss of Cav3.2 T-Type Channel Activity.” Molecular Brain, 2020.


Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the progressive loss of cortical, brain stem and spinal motor neurons that leads to muscle weakness and death. A previous study implicated CACNA1H encoding for Cav3.2 calcium channels as a susceptibility gene in ALS. In the present study, two heterozygous CACNA1H variants were identified by whole genome sequencing in a small cohort of ALS patients. These variants were functionally characterized using patch clamp electrophysiology, biochemistry assays, and molecular modeling. A previously unreported c.454GTAC > G variant produced an inframe deletion of a highly conserved isoleucine residue in Cav3.2 (p.ΔI153) and caused a complete loss-of-function of the channel, with an additional dominant-negative effect on the wild-type channel when expressed in trans. In contrast, the c.3629C > T variant caused a missense substitution of a proline with a leucine (p.P1210L) and produced a comparatively mild alteration of Cav3.2 channel activity. The newly identified ΔI153 variant is the first to be reported to cause a complete loss of Cav3.2 channel function. These findings add to the notion that loss-of-function of Cav3.2 channels associated with rare CACNA1H variants may be risk factors in the complex etiology of ALS.